COLL - Collegium downgraded by Piper Sandler over valuation
2024-05-10 13:12:30 ET
More on Collegium Pharmaceutical
- Collegium Pharmaceutical, Inc. (COLL) Q1 2024 Earnings Call Transcript
- Collegium Pharmaceutical Q4: The Beat Goes On
- Collegium Pharmaceutical's (COLL) Q4 2023 Earnings Call Transcript
- Collegium announces CEO Joe Ciaffoni to step down
- Collegium Pharmaceutical Non-GAAP EPS of $1.45 misses by $0.02, revenue of $144.9M misses by $2.04M